Project Management [Apply in 3 Minutes]

DS / DP BIOSIMILARS

About the company :

Biocon Biologics Limited (BBL) is a fully integrated, innovation-led company committed to transforming patients’ lives by enabling affordable access to high-quality biosimilars for patients and healthcare systems, either directly or through a network of partners and distributors, in over 100+ countries.

BBL has demonstrated success with multiple successful biosimilar approvals in U.S., Europe and several other advanced and developing countries. It has eight [1] commercialized products in global markets. It is the first company in the world to obtain U.S. Food and Drug Administration (FDA) approval for an interchangeable biosimilar, received for its Insulin Glargine.

The company has a broad pipeline of 20 biosimilar molecules spanning insulins, monoclonal antibodies and conjugated recombinant proteins with a strong focus on diabetology, oncology and immunology, targeting an over USD 70 billion addressable market by FY27.

Through its recent strategic alliance with the Serum Institute Life Sciences (SILS), BBL will be able to diversify its business beyond biosimilars and have access to a portfolio of vaccines targeting several communicable diseases.

Biocon Biologics has invested over USD 1 billion to date in R&D and global scale manufacturing and has end-to-end capabilities for producing drug substance, drug product and delivery devices across multiple sites in India and Malaysia.

It is also among the Top 15 global biopharma players in terms of installed capacity and has a strong track record of compliance and quality with GMP certifications and approvals from key regulators such as U.S. FDA, European Medicines Agency, Therapeutic Goods Administration (Australia), Health Canada, PMDA (Japan) and many others.

With a team of ~ 4,800 people, Biocon Biologics is committed to transforming healthcare and transforming lives by enabling affordable access to millions of patients’ worldwide.

For more information visit :

http : / / www.bioconbiologics.com

About the Function :

Projects & Engineering function manages capital investments for expansion of DS and DP manufacturing facilities globally that are either greenfield or brownfield. With a team of about 50 and split into various verticals including Process Engineering, Automation and Instrumentation, Electrical, Mechanical, Project Management, Commercial, Civil, and Site execution.

Project manager will manage the project in close coordination with all the stakeholders to ensure scope of the project is met.

About the Role :

• Responsible for management of the project from initiation, planning, execution, monitoring, controlling and closing of the project.
• Keeping a track of Project cost, schedule, scope and cash flow.
• Provide regular project updates, reports and status information.
• Coordinate with other Project verticals in preparing and tracking the project
• Identifying project risk, constraints and assess the same periodically.
• Ensuring compliance with statutory requirements.
• Finalizing the contracts of Design consultant and Construction management firm.
• Ensure effective communication with team members and stakeholders
• Strong stakeholder management skills
• Adherence to safety, Health, and Environment measures
• Open to travel(get deployed) in any part of India / out of India based on project requirements

Qualification Required :

Degree : BE / B.Tech in any field

Experience : 2 to 6 years in project management

Course :

Equal Opportunity Employer :

Biocon Biologics is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Biocon Biologics also complies with all applicable national, state and local laws governing non-discrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act.